Home » Topics » Regulatory

Regulatory
RSS

FDA approves Surfaxin

March 7, 2012

No Comments

First four-strain flu vaccine approved in U.S.

March 2, 2012

No Comments

Esmya approved in Europe

Feb. 27, 2012

No Comments

European Commission approves Glivec label update

Feb. 27, 2012

No Comments

FDA grants first approval for drug-eluting coronary stent use in AMI

Feb. 23, 2012

No Comments

BMS gains additional indication approvals for two anticancer drugs

Feb. 23, 2012

No Comments

Line extension for Zyprexa approved in Japan

Feb. 23, 2012

No Comments

Nippon Kayaku anticancer drugs approved for additional indications in Japan

Feb. 22, 2012

No Comments

FDA approves first medical therapy for endogenous Cushing's syndrome

Feb. 20, 2012

No Comments

Health Canada approves line extension for Prevnar 13

Feb. 17, 2012

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA approves Surfaxin

First four-strain flu vaccine approved in U.S.

Esmya approved in Europe

European Commission approves Glivec label update

FDA grants first approval for drug-eluting coronary stent use in AMI

BMS gains additional indication approvals for two anticancer drugs

Line extension for Zyprexa approved in Japan

Nippon Kayaku anticancer drugs approved for additional indications in Japan

FDA approves first medical therapy for endogenous Cushing's syndrome

Health Canada approves line extension for Prevnar 13

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Regulatory RSS

Regulatory
RSS